Correlation Between ARK Genomic and IShares Biotechnology
Can any of the company-specific risk be diversified away by investing in both ARK Genomic and IShares Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARK Genomic and IShares Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ARK Genomic Revolution and iShares Biotechnology ETF, you can compare the effects of market volatilities on ARK Genomic and IShares Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARK Genomic with a short position of IShares Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARK Genomic and IShares Biotechnology.
Diversification Opportunities for ARK Genomic and IShares Biotechnology
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ARK and IShares is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding ARK Genomic Revolution and iShares Biotechnology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Biotechnology ETF and ARK Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARK Genomic Revolution are associated (or correlated) with IShares Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Biotechnology ETF has no effect on the direction of ARK Genomic i.e., ARK Genomic and IShares Biotechnology go up and down completely randomly.
Pair Corralation between ARK Genomic and IShares Biotechnology
Given the investment horizon of 90 days ARK Genomic Revolution is expected to under-perform the IShares Biotechnology. In addition to that, ARK Genomic is 2.32 times more volatile than iShares Biotechnology ETF. It trades about 0.0 of its total potential returns per unit of risk. iShares Biotechnology ETF is currently generating about 0.02 per unit of volatility. If you would invest 13,224 in iShares Biotechnology ETF on August 30, 2024 and sell it today you would earn a total of 935.00 from holding iShares Biotechnology ETF or generate 7.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ARK Genomic Revolution vs. iShares Biotechnology ETF
Performance |
| Timeline |
| ARK Genomic Revolution |
| iShares Biotechnology ETF |
ARK Genomic and IShares Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ARK Genomic and IShares Biotechnology
The main advantage of trading using opposite ARK Genomic and IShares Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARK Genomic position performs unexpectedly, IShares Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Biotechnology will offset losses from the drop in IShares Biotechnology's long position.| ARK Genomic vs. Freedom Day Dividend | ARK Genomic vs. Franklin Templeton ETF | ARK Genomic vs. iShares MSCI China | ARK Genomic vs. Tidal Trust II |
| IShares Biotechnology vs. First Trust Exchange Traded | IShares Biotechnology vs. Ultimus Managers Trust | IShares Biotechnology vs. Horizon Kinetics Medical | IShares Biotechnology vs. Harbor Health Care |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |